Prediction of mortality in SSc-ILD depends on definition of ILD progression

被引：0

作者：

Hoffmann-Vold, Anna Maria ^{[1
]}

Petelytskab, Liubov ^{[2
]}

Fretheim, Havard ^{[1
]}

Barua, Imon ^{[1
]}

Becker, Mike ^{[2
]}

Bjorkekjaer, Hilde ^{[3
]}

Brunborg, Cathrine ^{[4
]}

Bruni, Cosimo ^{[5
]}

Diep, Phuong Phuong ^{[1
]}

Dobrota, Rucsandra ^{[5
]}

Durheim, Michael ^{[1
]}

Elhai, Muriel ^{[5
]}

Jordan, Suzana ^{[5
]}

Langballe, Emily ^{[1
]}

Midtvedt, Oyvind ^{[1
]}

Mihai, Carina ^{[5
]}

Molberg, Oyvind ^{[1
]}

Distler, Oliver ^{[5
]}

机构：

[1] Oslo Univ Hosp, Oslo, Norway

[2] Univ Hosp Zurich, Zurich, Switzerland

[3] Hosp Southern Norway, Kristiansand, Norway

[4] Oslo Univ Hopsital, Oslo, Norway

[5] Zurich Univ Hosp, Zurich, Switzerland

来源：

EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷

关键词：

D O I：

10.1183/13993003.congress-2023.PA2914

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页数：3

共 50 条

[21] Neue Wege in der Therapie der SSc-ILD: Was macht Sinn?New ways in the treatment of SSc-ILD: what makes sense?
Michael Kreuter
Anna-Maria Hoffmann-Vold
[J]. Der Pneumologe, 2019, 16 : 303 - 304
[22] Neue Wege in der Therapie der SSc-ILD: Was macht Sinn?New ways in the treatment of SSc-ILD: what makes sense?
Michael Kreuter
Anna-Maria Hoffmann-Vold
[J]. Zeitschrift für Rheumatologie, 2019, 78 : 863 - 864
[23] SSc-ILD pulmonary function dynamics - is "normal" dangerous?
Cotet, Marius-Alexandru
Gologanu, Daniela
Nedelcu, Valentin
Ion, Ion Andrei
Balea, Marius Ioan
Popescu, Daniela
Dima, Alina
Parvu, Magda
Pompilian, Valer
Nitescu, Doina
Caraiola, Simona
Ionescu, Razvan
Badea, Camelia
Pinte, Larisa
Baicus, Cristian-Rasvan
[J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
[24] UTILITY OF SERUM BIOMARKERS TO DETECT ILD IN IDIOPATHIC PULMONARY FIBROSIS (IPF) AND SCLERODERMA-ASSOCIATED ILD (SSC-ILD)
Jee, A.
Adelstein, S.
Sahhar, J.
Youssef, P.
Lai, D.
Hua, S.
[J]. RESPIROLOGY, 2019, 24 : 34 - 34
[25] IS THERE A DIFFERENCE BETWEEN THE SEXES IN THE RATE OF PROGRESSION OF SYSTEMIC SCLEROSIS-ASSOCIATED ILD (SSC-ILD)? DATA FROM THE SENSCIS TRIAL
Volkmann, E.
Vettori, S.
Varga, J.
Herrick, A.
Cutolo, M.
Cordeiro, A.
Azevedo, V. F.
Johnson, S.
Stock, C.
Gahlemann, M.
Moros, L.
Alves, M.
Mayes, M.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1114 - 1115
[26] Impact and outcome of COVID-19 on SSc-ILD
Hoffmann-Vold, Anna Maria
Brunborg, Cathrine
Tirelli, Francesca
Carreira, Patricia E.
Del Papa, Nicoletta
Mekinian, Arsene
Vonk, Madelon
Giollo, Alessandro
De Luca, Giacomo
De Santis, Maria
Campochiaro, Corrado
Mihai, Carina
Airo, Paolo
Lazzaroni, Maria-Grazia
Zanatta, Elisabetta
Foti, Rosario
Allanore, Yannick
Furst, Daniel E.
Cerinic-Matucci, Marco
Gabrielli, Armando
Distler, Oliver
[J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
[27] Factors Associated With Progression of Interstitial Lung Disease in Patients With Systemic Sclerosis (SSc-ILD)
Yosboot, A.
Muangchan, C.
Teerapuncharoen, K.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
[28] Nintedanib slows ILD progression in SSc
McHugh J.
[J]. Nature Reviews Rheumatology, 2019, 15 (7) : 384 - 384
[29] Dose adjustments in the SENSCIS trial of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD)
Highland, Kristin B.
Kuwana, Masataka
Azuma, Arata
Fischer, Aryeh
Maher, Toby M.
Mayes, Maureen D.
Raghu, Ganesh
Girard, Mannaig
Kohlbrenner, Veronika
Clerisme-Beaty, Emmanuelle
Alves, Margarida
Distler, Oliver
[J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
[30] Dose adjustments in the SENSCIS Trial of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD)
Kreuter, M.
Highland, K. B.
Kuwana, M.
Azuma, A.
Maher, T.
Mayes, M. D.
Raghu, G.
Girard, M.
Kohlbrenner, V
Clerisme-Beaty, E.
Alves, M.
Distler, O.
[J]. PNEUMOLOGIE, 2020, 74 : S55 - S56

← 1 2 3 4 5 →